A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
ReferenceBot (talk | contribs)
Changed an Item
 
(3 intermediate revisions by 3 users not shown)
Property / OpenAlex ID
 
Property / OpenAlex ID: W2047193122 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts / rank
 
Normal rank
Property / cites work
 
Property / cites work: Simple Sequential Boundaries for Treatment Selection in Multi‐Armed Randomized Clinical Trials with a Control / rank
 
Normal rank
Property / cites work
 
Property / cites work: Group Sequential Tests for Bivariate Response: Interim Analyses of Clinical Trials with Both Efficacy and Safety Endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Opportunities and Limitations / rank
 
Normal rank
Property / cites work
 
Property / cites work: Discrete Sequential Boundaries for Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Phase 2 and 3 Combination Designs to Accelerate Drug Development / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Simplex Method for Function Minimization / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4267796 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Estimating the dimension of a model / rank
 
Normal rank
Property / cites work
 
Property / cites work: A review of phase 2-3 clinical trial designs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding Based on Efficacy-Toxicity Trade-Offs / rank
 
Normal rank
Property / cites work
 
Property / cites work: Two-stage selection and testing designs for comparative clinical trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Approximately Optimal One-Parameter Boundaries for Group Sequential Trials / rank
 
Normal rank

Latest revision as of 23:42, 4 July 2024

scientific article
Language Label Description Also known as
English
A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity
scientific article

    Statements

    A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    5 March 2012
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Bayesian design
    0 references
    treatment selection
    0 references
    0 references
    0 references